Minocycline In Neurocognitive Outcomes - Sickle Cell Disease

Clinical trial NCT05605366 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05605366
Sponsor: University of Cincinnati
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Sickle Cell Disease Cognitive Impairment Cognitive Decline Cognitive Change Cognitive Dysfunction Cognitive Deficit Neuroinflammatory Response

Start date: 2026-12-01
Primary completion: 2027-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.